“We have to amplify what we saw at EBOVAC” – Assessing participant perceptions, attitudes, and acceptability of an ancillary care policy in an Ebola vaccine trial in the Democratic Republic of the Congo: A mixed methods study
Both quantitative and qualitative findings show high endorsement for the AC policy support, regardless of participants' personal use. This acceptability study highlights the importance of AC in clinical trials and comprehensive participant care in research.
Authors
- Sibyl Anthierens (ORCID: https://orcid.org/0000-0003-4762-1907)
- Jean‐Pierre Van Geertruyden (ORCID: https://orcid.org/0000-0001-5006-6364)
- Gwen Lemey (ORCID: https://orcid.org/0000-0002-2879-5330)
- Vivi Maketa (ORCID: https://orcid.org/0000-0002-9007-1376)
- Maha Salloum (ORCID: https://orcid.org/0000-0001-7174-4822)
- Pierre Van Damme (ORCID: https://orcid.org/0000-0002-8642-1249)
- Trésor Zola Matuvanga (ORCID: https://orcid.org/0000-0002-5830-415X)
- Ynke Larivière (ORCID: https://orcid.org/0000-0002-5422-0194)
- Raffaella Ravinetto (ORCID: https://orcid.org/0000-0001-7765-2443)
- Solange Milolo (ORCID: https://orcid.org/0000-0003-2507-4041)
- Hypolite Muhindo Mavoko (ORCID: https://orcid.org/0000-0002-3307-3324)
- Patrick Mitashi
Institutions
- University of Antwerp (BE)
- University of Kinshasa (CD)
- Instituut voor Tropische Geneeskunde (BE)
- University of the Western Cape (ZA)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-06-24
- DOI
- https://doi.org/10.1371/journal.pone.0325435
- Primary Topic
- Viral Infections and Outbreaks Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Horizon 2020